toad.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
Mastodon server operated by David Troy, a tech pioneer and investigative journalist addressing threats to democracy. Thoughtful participation and discussion welcome.

Administered by:

Server stats:

218
active users

#embargoes

0 posts0 participants0 posts today
petersuber<p><a href="https://fediscience.org/tags/SPARC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>SPARC</span></a> has released its own new info on the new <a href="https://fediscience.org/tags/NIH" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NIH</span></a> <a href="https://fediscience.org/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenAccess</span></a> policy.<br><a href="https://sparcopen.org/wp-content/uploads/2025/06/Update-to-NIH-PA-Policy-Deadline.pdf" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">sparcopen.org/wp-content/uploa</span><span class="invisible">ds/2025/06/Update-to-NIH-PA-Policy-Deadline.pdf</span></a></p><p>Excerpt:</p><p>&lt;blockquote&gt;<br>● The Policy requires immediate public access to articles -- <a href="https://fediscience.org/tags/embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>embargoes</span></a> are no longer allowed.<br>● NIH reiterates authors do not have to pay a fee to comply with the Policy.<br>● The Policy applies to manuscripts accepted for publication on or after July 1, 2025. This means the Policy will apply to existing grants if an article is accepted on or after that date.<br>● The Policy requires that final peer-reviewed manuscripts be submitted to <a href="https://fediscience.org/tags/PubMedCentral" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PubMedCentral</span></a> (<a href="https://fediscience.org/tags/PMC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PMC</span></a>) upon acceptance to be made publicly available immediately upon publication.<br>● The Policy requires that grantees explicitly grant the NIH the right to make the manuscript available in PMC without an embargo.<br>● The Policy does not explicitly grant full reuse rights of the manuscript to the public.<br>&lt;/blockquote&gt; </p><p><a href="https://fediscience.org/tags/Copyright" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Copyright</span></a> <a href="https://fediscience.org/tags/Embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Embargoes</span></a> <a href="https://fediscience.org/tags/GreenOA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GreenOA</span></a> <a href="https://fediscience.org/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Medicine</span></a> <a href="https://fediscience.org/tags/NelsonMemo" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NelsonMemo</span></a> <a href="https://fediscience.org/tags/OSTP" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OSTP</span></a></p>
petersuber<p>The <a href="https://fediscience.org/tags/NIH" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NIH</span></a> just released new info on its zero-embargo <a href="https://fediscience.org/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenAccess</span></a> policy, which takes effect next week (July 1).<br><a href="https://grants.nih.gov/policy-and-compliance/policy-topics/public-access" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grants.nih.gov/policy-and-comp</span><span class="invisible">liance/policy-topics/public-access</span></a></p><p>This includes:</p><p>* a new overview of the policy itself<br><a href="https://grants.nih.gov/policy-and-compliance/policy-topics/public-access/nih-public-access-policy-overview" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grants.nih.gov/policy-and-comp</span><span class="invisible">liance/policy-topics/public-access/nih-public-access-policy-overview</span></a></p><p>* a new overview of the methods for submitting papers to comply with the policy<br><a href="https://grants.nih.gov/policy-and-compliance/policy-topics/public-access/submitting-pubmed-central" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grants.nih.gov/policy-and-comp</span><span class="invisible">liance/policy-topics/public-access/submitting-pubmed-central</span></a></p><p>* and a new FAQ.<br><a href="https://grants.nih.gov/faqs#/public-access-policy" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grants.nih.gov/faqs#/public-ac</span><span class="invisible">cess-policy</span></a></p><p><a href="https://fediscience.org/tags/Embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Embargoes</span></a> <a href="https://fediscience.org/tags/GreenOA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GreenOA</span></a> <a href="https://fediscience.org/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Medicine</span></a> <a href="https://fediscience.org/tags/NelsonMemo" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NelsonMemo</span></a> <a href="https://fediscience.org/tags/PubMedCentral" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PubMedCentral</span></a> <a href="https://fediscience.org/tags/OSTP" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OSTP</span></a></p>
petersuber<p>Kudos to <a href="https://fediscience.org/tags/Canada" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Canada</span></a>'s three major research-funding agencies for their draft all-green, zero-embargo, rights-retention <a href="https://fediscience.org/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenAccess</span></a> policy.<br><a href="https://science.gc.ca/site/science/en/interagency-research-funding/policies-and-guidelines/open-access/draft-revised-tri-agency-open-access-policy-publications" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">science.gc.ca/site/science/en/</span><span class="invisible">interagency-research-funding/policies-and-guidelines/open-access/draft-revised-tri-agency-open-access-policy-publications</span></a></p><p>The agencies are the Canadian Institutes of Health Research (<a href="https://fediscience.org/tags/CIHR" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>CIHR</span></a>), the Natural Sciences and Engineering Research Council of Canada (<a href="https://fediscience.org/tags/NSERC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NSERC</span></a>) and the Social Sciences and Humanities Research Council of Canada (<a href="https://fediscience.org/tags/SSHRC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>SSHRC</span></a>) — sometimes known collectively as the <a href="https://fediscience.org/tags/TriAgency" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>TriAgency</span></a>.</p><p><a href="https://fediscience.org/tags/Copyright" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Copyright</span></a> <a href="https://fediscience.org/tags/Embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Embargoes</span></a> <a href="https://fediscience.org/tags/GreenOA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GreenOA</span></a> <a href="https://fediscience.org/tags/OpenLicenses" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenLicenses</span></a> <a href="https://fediscience.org/tags/RightsRetention" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>RightsRetention</span></a></p>
petersuber<p>Update. Also see:</p><p>* NIH Plan to Increase Findability and Transparency of Research Results Through the Use of Metadata and Persistent Identifiers<br><a href="https://osp.od.nih.gov/wp-content/uploads/2024/12/Metadata_PIDs.12.16.2024_PDF.pdf" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">osp.od.nih.gov/wp-content/uplo</span><span class="invisible">ads/2024/12/Metadata_PIDs.12.16.2024_PDF.pdf</span></a></p><p>* NIH Issues New Policy to Speed Access to Agency-Funded Research Results<br><a href="https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-issues-new-policy-speed-access-agency-funded-research-results" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">nih.gov/about-nih/who-we-are/n</span><span class="invisible">ih-director/statements/nih-issues-new-policy-speed-access-agency-funded-research-results</span></a></p><p>* Introducing the New NIH Public Access Policy<br><a href="https://osp.od.nih.gov/introducing-the-new-nih-public-access-policy/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">osp.od.nih.gov/introducing-the</span><span class="invisible">-new-nih-public-access-policy/</span></a></p><p>h/t <a href="https://fediscience.org/tags/GaryPrice" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GaryPrice</span></a></p><p><a href="https://fediscience.org/tags/Discoverability" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Discoverability</span></a> <a href="https://fediscience.org/tags/Embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Embargoes</span></a> <a href="https://fediscience.org/tags/Metadata" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Metadata</span></a> <a href="https://fediscience.org/tags/NelsonMemo" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NelsonMemo</span></a> <a href="https://fediscience.org/tags/NIH" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NIH</span></a> <a href="https://fediscience.org/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenAccess</span></a> <a href="https://fediscience.org/tags/OSTP" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OSTP</span></a> <a href="https://fediscience.org/tags/PIDs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>PIDs</span></a></p>
petersuber<p>The American Chemical Society (<a href="https://fediscience.org/tags/ACS" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ACS</span></a>) is proud of a new business model for <a href="https://fediscience.org/tags/hybrid" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>hybrid</span></a> <a href="https://fediscience.org/tags/journals" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>journals</span></a>. Payor institutions get "full reading access" &amp; their authors get the right make their ACS articles <a href="https://fediscience.org/tags/GreenOA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>GreenOA</span></a> without <a href="https://fediscience.org/tags/embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>embargoes</span></a>. <br><a href="https://www.acs.org/pressroom/newsreleases/2024/june/acs-publications-and-french-consortium-together-support-open-access-publishing.html" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">acs.org/pressroom/newsreleases</span><span class="invisible">/2024/june/acs-publications-and-french-consortium-together-support-open-access-publishing.html</span></a></p><p>PS: This is not a good deal. It asks universities to pay for the right to ensure unembargoed green OA. But rights-retaining <a href="https://fediscience.org/tags/authors" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>authors</span></a> &amp; <a href="https://fediscience.org/tags/universities" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>universities</span></a> already have this right. Another argument for <a href="https://fediscience.org/tags/RightsRetention" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>RightsRetention</span></a>.</p><p><a href="https://fediscience.org/tags/Copyright" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Copyright</span></a> <a href="https://fediscience.org/tags/ScholComm" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ScholComm</span></a></p>
v_i_o_l_a<p>""Publishing Embargoes and Versions of Preprints: Impact on the Dissemination of Information" @ Open Information Science: <a href="https://doi.org/10.1515/opis-2024-0002" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="">doi.org/10.1515/opis-2024-0002</span><span class="invisible"></span></a><br><a href="https://openbiblio.social/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenAccess</span></a> <a href="https://openbiblio.social/tags/copyright" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>copyright</span></a> <a href="https://openbiblio.social/tags/preprints" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>preprints</span></a> <a href="https://openbiblio.social/tags/embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>embargoes</span></a></p>
petersuber<p>Update. Kudos to the Association of Health Care Journalists (<a href="https://fediscience.org/tags/AHCJ" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>AHCJ</span></a>) for its campaign against the <a href="https://fediscience.org/tags/NEJM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NEJM</span></a> embargo against news outlets serving physicians. <a href="https://fediscience.org/tags/NEJM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NEJM</span></a> just dropped the embargo. <br><a href="https://healthjournalism.org/blog/2024/05/ahcj-advocacy-prompts-nejm-group-to-abandon-unfair-credential-policy/" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">healthjournalism.org/blog/2024</span><span class="invisible">/05/ahcj-advocacy-prompts-nejm-group-to-abandon-unfair-credential-policy/</span></a></p><p><a href="https://fediscience.org/tags/Embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Embargoes</span></a> <a href="https://fediscience.org/tags/Journals" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Journals</span></a> <a href="https://fediscience.org/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Medicine</span></a> <a href="https://fediscience.org/tags/ScholComm" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ScholComm</span></a></p>
petersuber<p>"The New England Journal of Medicine (<a href="https://fediscience.org/tags/NEJM" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NEJM</span></a>) is cutting off certain publications from advanced access to its embargoed journal articles. News outlets that report for physician readers will no longer meet criteria for embargoed access."<br><a href="https://www.medpagetoday.com/special-reports/exclusives/109756" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">medpagetoday.com/special-repor</span><span class="invisible">ts/exclusives/109756</span></a></p><p>PS: In other words, the readers who most need unembargoed access (for patient care and clinical application) will be denied unembargoed access. </p><p><a href="https://fediscience.org/tags/Embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Embargoes</span></a> <a href="https://fediscience.org/tags/Journals" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Journals</span></a> <a href="https://fediscience.org/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Medicine</span></a> <a href="https://fediscience.org/tags/ScholComm" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ScholComm</span></a></p>
petersuber<p>New study: "Within 3-5 years from their publication, two-thirds of <a href="https://fediscience.org/tags/ClinicalTrials" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>ClinicalTrials</span></a> published in the top medical journals lifted the <a href="https://fediscience.org/tags/embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>embargoes</span></a> for <a href="https://fediscience.org/tags/data" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>data</span></a> sharing that they had stated in their original data sharing statements. This shift toward greater openness is a positive development."<br><a href="https://jamanetwork.com/journals/jama/fullarticle/2813597" rel="nofollow noopener" target="_blank"><span class="invisible">https://</span><span class="ellipsis">jamanetwork.com/journals/jama/</span><span class="invisible">fullarticle/2813597</span></a><br>(<a href="https://fediscience.org/tags/paywalled" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>paywalled</span></a>)</p><p><a href="https://fediscience.org/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Medicine</span></a> <a href="https://fediscience.org/tags/OpenData" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenData</span></a></p>
petersuber<p><span class="h-card"><a href="https://mastodon.social/@hfalcke" class="u-url mention" rel="nofollow noopener" target="_blank">@<span>hfalcke</span></a></span> <br>Dropping <a href="https://fediscience.org/tags/embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>embargoes</span></a> accelerates research. It helps authors and their new work reach readers faster. It helps readers find and read new work faster, and that includes readers who happen to be journalists. Once research is ready to share, artificial delays in sharing it are an artificial brake on applying and building on that research. Dropping embargoes is esp important for time-sensitive research, such as developing tests and vaccines during a pandemic.</p>
petersuber<p>Update. The <a href="https://fediscience.org/tags/EuropeanCouncil" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>EuropeanCouncil</span></a> just adopted the <a href="https://fediscience.org/tags/OpenScience" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenScience</span></a> proposal anticipated earlier this month (this thread, above). No <a href="https://fediscience.org/tags/embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>embargoes</span></a>. No <a href="https://fediscience.org/tags/APCs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>APCs</span></a>. <a href="https://fediscience.org/tags/Nonprofit" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Nonprofit</span></a> publishing. <a href="https://fediscience.org/tags/OpenLicenses" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenLicenses</span></a>. <a href="https://fediscience.org/tags/OpenInfrastructure" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenInfrastructure</span></a>. <a href="https://www.consilium.europa.eu/en/press/press-releases/2023/05/23/council-calls-for-transparent-equitable-and-open-access-to-scholarly-publications/" rel="nofollow noopener" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">consilium.europa.eu/en/press/p</span><span class="invisible">ress-releases/2023/05/23/council-calls-for-transparent-equitable-and-open-access-to-scholarly-publications/</span></a> </p><p>While this is not yet policy, it's a weighty recommendation to the Commission and member states.</p>
petersuber<p>This is big. No <a href="https://fediscience.org/tags/embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>embargoes</span></a>. No <a href="https://fediscience.org/tags/APCs" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>APCs</span></a>. </p><p>"The <a href="https://fediscience.org/tags/EU" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>EU</span></a> is ready to agree that immediate <a href="https://fediscience.org/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenAccess</span></a> to papers reporting publicly funded research should become the norm, w/o authors having to pay fees &amp; that the bloc should support <a href="https://fediscience.org/tags/nonprofit" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>nonprofit</span></a> scholarly publishing models.</p><p>In a move that could send shockwaves through commercial scholarly <a href="https://fediscience.org/tags/publishing" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>publishing</span></a>, the positions are due to be adopted by the Council of the EU member state governments later this month."<br><a href="https://www.researchprofessionalnews.com/rr-news-europe-infrastructure-2023-5-eu-ready-to-back-immediate-open-access-without-author-fees/" rel="nofollow noopener" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">researchprofessionalnews.com/r</span><span class="invisible">r-news-europe-infrastructure-2023-5-eu-ready-to-back-immediate-open-access-without-author-fees/</span></a> </p><p><a href="https://fediscience.org/tags/Europe" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Europe</span></a> <a href="https://fediscience.org/tags/RightsRetention" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>RightsRetention</span></a></p>
petersuber<p>3/ They also support repository-based (<a href="https://fediscience.org/tags/green" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>green</span></a>) <a href="https://fediscience.org/tags/openaccess" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>openaccess</span></a> for authors, whether or not their research was funded and whether or not the funder had an OA policy. The permission for green OA can come from authors, not publishers, and can disregard publisher attempts to require <a href="https://fediscience.org/tags/embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>embargoes</span></a>.</p><p>They help universities get all articles by affiliates into their OA repositories, not just those subject to funder policies.</p>
Kevin Karhan :verified:One cheer for #Twitter
petersuber<p>NASA just released an important update to its open science policies.<br><a href="https://science.nasa.gov/researchers/science-data/science-information-policy" rel="nofollow noopener" target="_blank"><span class="invisible">https://</span><span class="ellipsis">science.nasa.gov/researchers/s</span><span class="invisible">cience-data/science-information-policy</span></a></p><p>SPARC has written a useful summary.<br><a href="https://sparcopen.org/wp-content/uploads/2022/12/Overview-NASA-SMD-41a-Info-Policy.pdf" rel="nofollow noopener" target="_blank"><span class="invisible">https://</span><span class="ellipsis">sparcopen.org/wp-content/uploa</span><span class="invisible">ds/2022/12/Overview-NASA-SMD-41a-Info-Policy.pdf</span></a></p><p>From SPARC: "While this policy does not serve as NASA's official response to the OSTP Nelson Memorandum, it is a good indication of what we are likely to ultimately see in NASA's agency-wide public access plan, which is due out in February 2023."</p><p><a href="https://fediscience.org/tags/NASA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NASA</span></a> <a href="https://fediscience.org/tags/OpenAccess" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenAccess</span></a> <a href="https://fediscience.org/tags/OpenScience" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenScience</span></a> <a href="https://fediscience.org/tags/OpenData" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenData</span></a> <a href="https://fediscience.org/tags/OpenSource" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenSource</span></a> <a href="https://fediscience.org/tags/Embargoes" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Embargoes</span></a> <a href="https://fediscience.org/tags/OSTP" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OSTP</span></a> <a href="https://fediscience.org/tags/OpenInTheUSA" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>OpenInTheUSA</span></a> <a href="https://fediscience.org/tags/SPARC" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>SPARC</span></a></p>